Nutrition in cardiovascular disease: salt in hypertension and heart failure
He et al.
Eur Heart J 2011;0:ehr194v1-ehr194.
ABSTRACT
| FULL TEXT
Effect of short-term NSAID use on echocardiographic parameters in elderly people: a population-based cohort study
van den Hondel et al.
Heart 2011;97:540-543.
ABSTRACT
| FULL TEXT
Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events
Liu et al.
Proc. Natl. Acad. Sci. USA 2010;107:17017-17022.
ABSTRACT
| FULL TEXT
Palliative Care in Congestive Heart Failure
Goodlin
J Am Coll Cardiol 2009;54:386-396.
ABSTRACT
| FULL TEXT
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program
Krum et al.
Eur J Heart Fail 2009;11:542-550.
ABSTRACT
| FULL TEXT
Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies
Dunn et al.
Nutr Clin Pract 2009;24:60-75.
ABSTRACT
| FULL TEXT
Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials
Scott et al.
Eur J Heart Fail 2008;10:1102-1107.
ABSTRACT
| FULL TEXT
Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Schocken et al.
Circulation 2008;117:2544-2565.
ABSTRACT
| FULL TEXT
Review: Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema?
Aneja and Farkouh
Ther Adv Cardiovasc Dis 2008;2:53-66.
ABSTRACT
Adverse effects of spinal manipulation: a systematic review
Ernst
JRSM 2007;100:330-338.
ABSTRACT
| FULL TEXT
Coxibs and Heart Disease: What We Have Learned and What Else We Need to Know
Zarraga and Schwarz
J Am Coll Cardiol 2007;49:1-14.
ABSTRACT
| FULL TEXT
Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population
Huerta et al.
Heart 2006;92:1610-1615.
ABSTRACT
| FULL TEXT
Understanding the NSAID related risk of vascular events.
Vonkeman et al.
BMJ 2006;332:895-898.
FULL TEXT
Can Natriuretic Peptide Levels Predict the Cardiovascular Complications of COX-2 Inhibitors and Nonsteroidal Anti-inflammatory Drugs?
Blankfield
J Am Board Fam Med 2006;19:178-182.
ABSTRACT
| FULL TEXT
Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors
Juhlin et al.
Eur J Heart Fail 2005;7:1049-1056.
ABSTRACT
| FULL TEXT
Aspirin Use in Chronic Heart Failure: What Should We Recommend to the Practitioner?
Massie
J Am Coll Cardiol 2005;46:963-966.
ABSTRACT
| FULL TEXT
Obstructive sleep apnea: Diagnosis, medical management and dental implications
MAGLIOCCA and HELMAN
Journal of the American Dental Association 2005;136:1121-1129.
ABSTRACT
| FULL TEXT
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei et al.
ANN INTERN MED 2004;141:764-770.
ABSTRACT
| FULL TEXT
Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs
Dieppe et al.
BMJ 2004;329:31-34.
FULL TEXT
Palliative Care for Patients With Heart Failure
Pantilat and Steimle
JAMA 2004;291:2476-2482.
ABSTRACT
| FULL TEXT
Keeping Your Patient With Heart Failure Safe: A Review of Potentially Dangerous Medications
Amabile and Spencer
Arch Intern Med 2004;164:709-720.
FULL TEXT
Both Thrombotic and Nonthrombotic Cardiovascular and Cerebrovascular Side Effects of Nonsteroidal Anti-Inflammatory Drugs Should Be Considered
Stollberger and Finsterer
Stroke 2004;35:e26-e26.
FULL TEXT
Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans
Hawkey et al.
Gut 2003;52:1537-1542.
ABSTRACT
| FULL TEXT
Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention
Podichetty et al.
Postgrad. Med. J. 2003;79:627-633.
ABSTRACT
| FULL TEXT
Using Bayes' nomogram to help interpret odds ratios
Page and Attia
Evid. Based Med. 2003;8:132-134.
FULL TEXT
Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance
Meune et al.
Journal of Renin-Angiotensin-Aldosterone System 2003;4:149-154.
ABSTRACT
Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
Ott et al.
J. Thorac. Cardiovasc. Surg. 2003;125:1481-1492.
ABSTRACT
| FULL TEXT
Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors
Hawkey and Langman
Gut 2003;52:600-608.
ABSTRACT
| FULL TEXT
Key questions concerning paracetamol and NSAIDs for osteoarthritis
Courtney and Doherty
Ann Rheum Dis 2002;61:767-773.
FULL TEXT
The management of hyperuricemia and gout in patients with heart failure
Spieker et al.
Eur J Heart Fail 2002;4:403-410.
FULL TEXT
Cyclooxygenase inhibition: between the devil and the deep blue sea
Hawkey
Gut 2002;50:iii25-30.
ABSTRACT
| FULL TEXT
Association of Nonsteroidal Anti-inflammatory Drugs With First Occurrence of Heart Failure and With Relapsing Heart Failure: The Rotterdam Study
Feenstra et al.
Arch Intern Med 2002;162:265-270.
ABSTRACT
| FULL TEXT
Aspirin, like all other drugs, is a poison
Tramer
BMJ 2000;321:1170-1171.
FULL TEXT
NSAIDs, Intestinal Cell Integrity, and Bacterial Translocation in Chronic Heart Failure
Rauchhaus et al.
Arch Intern Med 2000;160:3004-3005.
FULL TEXT
Heart Failure Hospitalizations Associated with Recent NSAID Use
Journal Watch Cardiology 2000;2000:7-7.
FULL TEXT